Yuhee Ryu

900 total citations
19 papers, 774 citations indexed

About

Yuhee Ryu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Yuhee Ryu has authored 19 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Yuhee Ryu's work include Histone Deacetylase Inhibitors Research (7 papers), Cardiac Fibrosis and Remodeling (6 papers) and Signaling Pathways in Disease (5 papers). Yuhee Ryu is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Cardiac Fibrosis and Remodeling (6 papers) and Signaling Pathways in Disease (5 papers). Yuhee Ryu collaborates with scholars based in South Korea, China and Germany. Yuhee Ryu's co-authors include Myung Ho Jeong, Hae Jin Kee, Sin Young Choi, Gwi Ran Kim, Jin Li, Simei Sun, Zhe Piao, Jae Yeong Cho, Hyung-Seok Kim and Young Mi Seok and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hypertension.

In The Last Decade

Yuhee Ryu

19 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuhee Ryu South Korea 18 444 133 114 78 63 19 774
Gwi Ran Kim South Korea 18 473 1.1× 142 1.1× 121 1.1× 78 1.0× 65 1.0× 22 818
Sin Young Choi South Korea 18 471 1.1× 136 1.0× 122 1.1× 78 1.0× 64 1.0× 26 823
Hong-Ling Tan China 22 570 1.3× 79 0.6× 109 1.0× 80 1.0× 51 0.8× 63 1.2k
Rufeng Ma China 16 657 1.5× 48 0.4× 115 1.0× 64 0.8× 72 1.1× 24 1.3k
Chia-Yao Shen Taiwan 19 387 0.9× 164 1.2× 54 0.5× 36 0.5× 56 0.9× 39 836
Sana Irfan Khan India 15 321 0.7× 59 0.4× 94 0.8× 71 0.9× 38 0.6× 31 946
Niloy Bhattacharjee India 11 347 0.8× 60 0.5× 117 1.0× 70 0.9× 57 0.9× 11 955
Jung Joo Yoon South Korea 20 566 1.3× 75 0.6× 45 0.4× 83 1.1× 83 1.3× 67 1.1k
Juntian Liu China 14 313 0.7× 66 0.5× 85 0.7× 37 0.5× 73 1.2× 31 786

Countries citing papers authored by Yuhee Ryu

Since Specialization
Citations

This map shows the geographic impact of Yuhee Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhee Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhee Ryu more than expected).

Fields of papers citing papers by Yuhee Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhee Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhee Ryu. The network helps show where Yuhee Ryu may publish in the future.

Co-authorship network of co-authors of Yuhee Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuhee Ryu. A scholar is included among the top collaborators of Yuhee Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuhee Ryu. Yuhee Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kee, Hae Jin, Yuhee Ryu, Young Mi Seok, et al.. (2019). Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice. Clinical Hypertension. 25(1). 13–13. 32 indexed citations
2.
Sun, Simei, Hae Jin Kee, Yuhee Ryu, et al.. (2019). Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure. Scientific Reports. 9(1). 3018–3018. 17 indexed citations
3.
Ryu, Yuhee, Hae Jin Kee, Simei Sun, et al.. (2019). Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension. PLoS ONE. 14(3). e0213186–e0213186. 35 indexed citations
4.
Choi, Sin Young, Hae Jin Kee, Simei Sun, et al.. (2019). Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension. Journal of Cellular and Molecular Medicine. 23(4). 2801–2812. 23 indexed citations
5.
Li, Jin, Simei Sun, Yuhee Ryu, et al.. (2018). Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure. Scientific Reports. 8(1). 9302–9302. 70 indexed citations
6.
Choi, Sin Young, Hae Jin Kee, Jin Li, et al.. (2018). Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat. Biomedicine & Pharmacotherapy. 101. 145–154. 43 indexed citations
7.
Sun, Simei, Hae Jin Kee, Jin Li, et al.. (2018). Gentisic acid attenuates pressure overload‐induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway. Journal of Cellular and Molecular Medicine. 22(12). 5964–5977. 25 indexed citations
8.
Sun, Simei, Tianyi Li, Jin Li, et al.. (2018). Dendropanax morbifera Prevents Cardiomyocyte Hypertrophy by Inhibiting the Sp1/GATA4 Pathway. The American Journal of Chinese Medicine. 46(5). 1021–1044. 21 indexed citations
10.
Li, Jin, Zhe Piao, Simei Sun, et al.. (2017). Gallic acid attenuates pulmonary fibrosis in a mouse model of transverse aortic contraction-induced heart failure. Vascular Pharmacology. 99. 74–82. 18 indexed citations
11.
Li, Jin, Zhe Piao, Simei Sun, et al.. (2017). Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats. Scientific Reports. 7(1). 15607–15607. 87 indexed citations
12.
Li, Jin, Zhe Piao, Simei Sun, et al.. (2017). Gallic acid attenuates calcium calmodulin‐dependent kinase II‐induced apoptosis in spontaneously hypertensive rats. Journal of Cellular and Molecular Medicine. 22(3). 1517–1526. 24 indexed citations
13.
Kim, Gwi Ran, Soo‐Na Cho, Hyung‐Seok Kim, et al.. (2016). Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension. Journal of Hypertension. 34(11). 2206–2219. 28 indexed citations
14.
Ryu, Yuhee, Jin Li, Hae Jin Kee, et al.. (2016). Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Scientific Reports. 6(1). 34790–34790. 88 indexed citations
15.
Kee, Hae Jin, Gwi Ran Kim, Sin Young Choi, et al.. (2016). Expression of Class I and Class II a/b Histone Deacetylase is Dysregulated in Hypertensive Animal Models. Korean Circulation Journal. 47(3). 392–392. 8 indexed citations
16.
Choi, Sin Young, Hae Jin Kee, Thomas Kurz, et al.. (2016). Class I HDACs specifically regulate E‐cadherin expression in human renal epithelial cells. Journal of Cellular and Molecular Medicine. 20(12). 2289–2298. 34 indexed citations
17.
Choi, Sin Young, Zhe Piao, Jin Li, et al.. (2016). Piceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK Signaling. PLoS ONE. 11(11). e0167340–e0167340. 42 indexed citations
18.
Choi, Sin Young, Yuhee Ryu, Hae Jin Kee, et al.. (2015). Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes. Vascular Pharmacology. 72. 130–140. 73 indexed citations
19.
Kee, Hae Jin, Soo‐Na Cho, Gwi Ran Kim, et al.. (2014). Gallic acid inhibits vascular calcification through the blockade of BMP2–Smad1/5/8 signaling pathway. Vascular Pharmacology. 63(2). 71–78. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026